Oral iron chelation and the treatment of iron overload in a pediatric hematology center

Pediatric Blood & Cancer
Jean L RaphaelBrigitta U Mueller

Abstract

Recent advances have led to the development of oral iron chelators, which have changed clinical practice. The objective of this study was to descriptively assess the use of one such agent, deferasirox, as standard of care treatment in a large pediatric hematology center. We retrospectively studied all patients at the Texas Children's Hematology Center who were previously or currently treated with deferasirox. We gathered data on demographics, clinical diagnoses, length of time on chronic transfusions, previous use of deferoxamine, adherence to therapy, and reasons for discontinuation. We also assessed changes in serum ferritin, liver function tests, and creatinine for those on deferasirox for a minimum of 12 months. Fifty-nine patients were studied. Eighty-one percent of patients treated with deferasirox had a diagnosis of sickle cell disease. The mean baseline ferritin level for our study population was 2,117 ng/ml (range 754-7,211). Fifty-three percent of patients had been previously treated with deferoxamine. Adherence to oral therapy was documented in 76% of patients. For those on deferasirox for a minimum of 12 months, serum ferritin decreased in 30% of patients (44% of compliant patients, 11% of poorly compliant patients)...Continue Reading

References

Nov 1, 1980·Hypertension·R B HaynesJ Mukherjee
Jan 1, 1996·Acta Haematologica·V Gabutti, A Piga
Jul 8, 1999·The New England Journal of Medicine·N F Olivieri
Feb 24, 2001·Seminars in Hematology·A R Cohen, M B Martin
Apr 25, 2001·European Journal of Clinical Pharmacology·R ArborettiUNKNOWN Italian Colaborative Group on Thalassarmia
Nov 13, 2001·British Journal of Haematology·J B Porter
Jul 23, 2002·JAMA : the Journal of the American Medical Association·Cynthia A JackeviciusJack V Tu
Nov 6, 2002·International Journal of Hematology·Robert S BrittonBruce R Bacon
Dec 11, 2002·JAMA : the Journal of the American Medical Association·R Brian HaynesAmit X Garg
Feb 18, 2003·The American Journal of the Medical Sciences·Christine E McLarenUNKNOWN Hemochromatosis and Iron Overload Study Research Investigators
Feb 21, 2003·Journal of Child Neurology·Jeffrey SchatzMichael R DeBaun
Apr 8, 2003·Current Medicinal Chemistry·Hanspeter NickDaniele Alberti
Oct 9, 2003·British Journal of Haematology·Elizabeth A ManciUNKNOWN Investigators of the Cooperative Study of Sickle Cell Disease
Nov 25, 2003·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Joyce CramerUNKNOWN VA Naltrexone Study Group 425
Dec 17, 2004·Pediatric Blood & Cancer·Marsha J TreadwellElliott Vichinsky
Aug 5, 2005·The New England Journal of Medicine·Lars Osterberg, Terrence Blaschke
Nov 4, 2005·The New England Journal of Medicine·Ronald J Campbell
Jan 20, 2007·British Journal of Haematology·Elliott VichinskyUNKNOWN Deferasirox in Sickle Cell Investigators

❮ Previous
Next ❯

Citations

Nov 29, 2012·Pediatric Cardiology·Arpan R Doshi, Linda B Pauliks
Jan 12, 2010·Pharmacy World & Science : PWS·Tiene BautersBarbara de Moerloose
Dec 10, 2013·Hematology·John Porter, Maciej Garbowski
May 20, 2011·Journal of Clinical Pharmacy and Therapeutics·L B JordanM S Duh
Jun 29, 2011·British Journal of Haematology·Gaetano LucaniaAurelio Maggio
Jun 19, 2013·Pediatric Blood & Cancer·Jean L RaphaelAngela M Ellison
Feb 8, 2011·Pediatric Blood & Cancer·Michelle N RheaultClifford E Kashtan
Jun 2, 2009·European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology·Claudia Stöllberger, Josef Finsterer
Aug 22, 2013·The Cochrane Database of Systematic Reviews·Sheila A FisherDavid J Roberts
Aug 24, 2013·The Cochrane Database of Systematic Reviews·Sheila A FisherDavid J Roberts
Jun 4, 2014·The Cochrane Database of Systematic Reviews·Joerg J MeerpohlDirk Bassler
Jun 20, 2019·JMIR MHealth and UHealth·Kristina CurtisStephan Lobitz
Sep 8, 2020·Journal of the National Medical Association·Charity I OyedejiNirmish Shah

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.